Karyopharm Therapeutics Inc.
NASDAQ: KPTI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard A. Paulson
- Employees
- 279
- Headquarters
- Newton, United States
- IPO year
- 2013
- Market cap
- $206.7M
- Website
- https://www.karyopharm.com
Loading KPTI…
Loading profile data…Frequently asked questions about KPTI
What does Karyopharm Therapeutics Inc. (KPTI) do?
Karyopharm Therapeutics Inc. is a pharmaceutical company that has already brought products to market, focusing on identifying, advancing, and selling medications designed to disrupt nuclear export pathways. These drugs are primarily aimed at treating cancer and various other illnesses. The company's strategy involves researching, creating, and m...
Where does KPTI trade?
Karyopharm Therapeutics Inc. (KPTI) trades on the NASDAQ Global Select.
What sector is KPTI in?
Karyopharm Therapeutics Inc. (KPTI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Karyopharm Therapeutics Inc.?
Richard A. Paulson is the chief executive officer of Karyopharm Therapeutics Inc. (KPTI).
Where is Karyopharm Therapeutics Inc. headquartered?
Karyopharm Therapeutics Inc. is headquartered in United States.
Does KPTI pay a dividend?
Karyopharm Therapeutics Inc. (KPTI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KPTI go public?
Karyopharm Therapeutics Inc. (KPTI) completed its initial public offering in 2013.